
Sign up to save your podcasts
Or
Many people are worried that their favorite deodorant is going to cause them an early death, but when it comes down to it, we’re more worried that we’re going to smell like death. This conundrum perfectly articulates the juggling act between the short term benefit and long term risk with skin care products. In an ideal world, regulators would keep us from harm’s way. In the real world, long-term cancer risk, hormone disruption, and even organ damage are difficult to track and quantify so this is an evolving discussion. On this week’s podcast, you’ll meet the CEO of a testing company focused on safety and efficacy for manufacturers.
Listen and learn:
Links
dermatest.com
ABOUT OUR GUEST
Marcel Voss is the CEO of Dermatest GmbH, a company that specializes in skin testing and analysis.
Like the Show?
4.8
928928 ratings
Many people are worried that their favorite deodorant is going to cause them an early death, but when it comes down to it, we’re more worried that we’re going to smell like death. This conundrum perfectly articulates the juggling act between the short term benefit and long term risk with skin care products. In an ideal world, regulators would keep us from harm’s way. In the real world, long-term cancer risk, hormone disruption, and even organ damage are difficult to track and quantify so this is an evolving discussion. On this week’s podcast, you’ll meet the CEO of a testing company focused on safety and efficacy for manufacturers.
Listen and learn:
Links
dermatest.com
ABOUT OUR GUEST
Marcel Voss is the CEO of Dermatest GmbH, a company that specializes in skin testing and analysis.
Like the Show?
3,318 Listeners
1,110 Listeners
565 Listeners
12,625 Listeners
1,247 Listeners
2,474 Listeners
2,045 Listeners
3,507 Listeners
3,524 Listeners
9,312 Listeners
8,098 Listeners
608 Listeners
1,334 Listeners
28,999 Listeners
1,196 Listeners